加拿大多中心IMPROVE-CHF 研究初步结果表明N端BNP前体蛋白可改善对疑似急性心衰患者的处置 -国际循环网

当前位置：循环首页>正文

加拿大多中心IMPROVE-CHF 研究初步结果表明N端BNP前体蛋白可改善对疑似急性心衰患者的处置

N-Terminal proB-type Natriuretic Peptide Improves the Management of Patients with Suspected Acute Heart FailurePrimary Results of the Canadian Multicenter IMPROVE-CHF Study

作者:国际循环网日期:2006/12/31 0:00:00

Gordon W. Moe， MD; Jonathan Howlett， MD; Hanna Zowall， PHD; for the Canadian Multicenter IMPROVE-CHF Study Investigators

4631 per patient， P=0.017)（Table 2 Clinical Characteristics and Outcomes of Patients Managed With and Those Without the Knowledge of NT-proBNP Results）.

Summary and Conclusions Results of the IMPROVE-CHF trial show that in a universal access publicly-funded health care system that mandates judicious resource allocation， the use of NT-proBNP testing in conjunction with clinical assessment improves the overall management of patients presenting to ED with suspected acute HF， through the facilitation of diagnosis， risk stratification and cost savings that is accompanied by an improvement in selected outcomes 上一页 [1] [2] [3]

版面编辑：国际循环